Early treatment is associated with improved cognition in hurler syndrome

Annals of Neurology

Volumn 76, Issue 5, 2014, Pages 747-753

  Poe, Michele D ^a   Chagnon, Sarah L ^a   Escolar, Maria L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITION; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEARING; HUMAN; HURLER SYNDROME; LANGUAGE ABILITY; MALE; NERVE CELL DIFFERENTIATION; VISION; ADOLESCENT; AGE; CHILD DEVELOPMENT; COGNITION DISORDERS; COMPLICATION; EARLY INTERVENTION; INFANT; LANGUAGE; MUCOPOLYSACCHARIDOSIS I; NEUROPSYCHOLOGICAL TEST; PRESCHOOL CHILD; PROCEDURES; PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; AGE FACTORS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; COGNITION DISORDERS; CORD BLOOD STEM CELL TRANSPLANTATION; EARLY MEDICAL INTERVENTION; FEMALE; HEARING; HUMANS; INFANT; LANGUAGE; MALE; MUCOPOLYSACCHARIDOSIS I; NEUROPSYCHOLOGICAL TESTS; VISION, OCULAR;

EID: 84912535118     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24246     Document Type: Article

References (35)

1. Aldenhoven M, Boelens JJ, de Koning TJ. The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 2008;14:485-498.
2. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill, 2001:3421-3452.
3. Bunge S, Clements PR, Byers S, et al. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim Biophys Acta 1998;1407:249-256.
4. Chkioua L, Khedhiri S, Ben Turkia H, et al. Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population. Diagn Pathol 2011;6:113.
5. Wang X, Zhang W, Shi H, et al. Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis. Clin Genet 2012;81:443-452.
6. Yamagishi A, Tomatsu S, Fukuda S, et al. Mucopolysaccharidosis type I: identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations. Hum Mutat 1996;7:23-29.
7. Voskoboeva EY, Krasnopolskaya XD, Mirenburg TV, et al. Molecular genetics of mucopolysaccharidosis type I: mutation analysis among the patients of the former Soviet Union. Mol Genet Metab 1998;65:174-180.
8. Vazna A, Beesley C, Berna L, et al. Mucopolysaccharidosis type I in 21 Czech and Slovak patients: mutation analysis suggests a functional importance of C-terminus of the IDUA protein. Am J Med Genet A 2009;149A:965-974.
9. Bertola F, Filocamo M, Casati G, et al. IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel alpha-L-iduronidase (IDUA) alleles. Hum Mutat 2011;32: E2189-E2210.
10. Hobbs JR, Hugh-Jones K, Barrett AJ, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981;2:709-712.
11. Kakkis ED, Muenzer J, Tiller GE, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344:182-188.
12. Dickson P, Peinovich M, McEntee M, et al. Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I. J Clin Invest 2008;118:2868-2876.
13. Tolar J, Dickson P, Orchard PJ. Intravenous and intrathecal enzyme replacement before and after hematopoietic cell transplantation for Hurler syndrome. Biol Blood Marrow Transplant 2009;15:74.
14. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005;352:2069-2081.
15. Staba SL, Escolar ML, Poe M, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004;350:1960-1969.
16. Beam D, Poe MD, Provenzale JM, et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant 2007;13:665-674.
17. Prasad VK, Mendizabal A, Parikh SH, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008;112:2979-2989.
18. Martin HR, Poe MD, Provenzale JM, et al. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant 2013;19: 616-624.
19. Martin PL, Carter SL, Kernan NA, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006;12:184-194.
20. Malm G, Gustafsson B, Berglund G, et al. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT). Acta Paediatr 2008; 97:1108-1112.
21. Tolar J, Grewal SS, Bjoraker KJ, et al. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplant 2008;41:531-535.
22. Orchard PJ, Milla C, Braunlin E, et al. Pre-transplant risk factors affecting outcome in Hurler syndrome. Bone Marrow Transplant 2010;45:1239-1246.
23. Eisengart JB, Rudser KD, Tolar J, et al. Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. J Pediatr 2013;162:375.e1-380.e1.
24. Jacobson P, Park JJ, DeFor TE, et al. Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation. Bone Marrow Transplant 2001;27:855-861.
25. Souillet G, Guffon N, Maire I, et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 2003; 31:1105-1117.
26. Guffon N, Souillet G, Maire I, et al. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998;133:119-125.
27. Vellodi A, Young EP, Cooper A, et al. Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 1997;76:92-99.
28. Peters C, Balthazor M, Shapiro EG, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996;87:4894-4902.
29. Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLAhaploidentical related donor bone marrow transplantation in fiftyfour children. The Storage Disease Collaborative Study Group. Blood 1998;91:2601-2608.
30. Shapiro EG, Lockman LA, Balthazor M, Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995;18:413-429.
31. Whitley CB, Belani KG, Chang PN, et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet 1993;46:209-218.
32. Shapiro E, Guler OE, Rudser K, et al. An exploratory study of brain function and structure in mucopolysaccharidosis type 1: long term observations following hematopoietic cell transplantation. Mol Genet Metab 2012;107:116-121.
33. Griguli L, Sykora KW, Tenger A, et al. Variable disease progression after successful stem cell transplantation: prospective followup investigations in eight patients with Hurler syndrome. Pediatr Transplant 2011;15:861-869.
34. Kupst MJ, Penati B, Debban B, et al. Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study. Bone Marrow Transplant 2002;30:609-617.
35. Phipps S, Rai SN, Leung WH, et al. Cognitive and academic consequences of stem-cell transplantation in children. J Clin Oncol 2008;26:2027-2033.